COM:MADRIGALPHARMA
Madrigal Pharmaceuticals
- Stock
Last Close
329.24
22/11 21:00
Market Cap
7.58B
Beta: -
Volume Today
532.84K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||||
average payables | 6.13M - | 4.86M 20.59% | 2.22M 54.38% | 1.03M 53.56% | 1.35M 30.57% | 2.21M 64.10% | 1.83M 17.01% | 1.10M 40.11% | 11.20M 920.36% | 22.61M 101.86% | 25.94M 14.73% | |
average receivables | ||||||||||||
book value per share | 24.21 - | 23.15 4.38% | 294.76 1,173.38% | 7.00 97.63% | 14.88 112.77% | 32.24 116.57% | 27.06 16.06% | 15.54 42.59% | 11.86 23.66% | 11.52 2.88% | 0.02 99.81% | |
capex per share | -0.38 - | -0.05 86.51% | -0.34 562.76% | -0.00 99.83% | -0.01 1,625.02% | -0.00 85.44% | -0.01 651.45% | -0.02 93.53% | -0.01 41.54% | -0.01 0.18% | -0.00 99.37% | |
capex to depreciation | -1.49 - | -0.21 85.64% | -0.09 59.05% | -19.74 22,434.92% | -1.62 91.78% | -0.23 85.88% | -1.54 570.13% | -0.71 53.82% | -0.52 27.23% | -0.46 9.96% | -2.81 503.97% | |
capex to operating cash flow | 0.01 - | 0.00 81.63% | 0.00 55.50% | 0.00 78.45% | 0.01 3,102.02% | 0.00 84.60% | 0.00 379.09% | 0.00 48.70% | 0.00 46.39% | 0.00 15.08% | 0.00 372.67% | |
capex to revenue | ||||||||||||
cash per share | 45.11 - | 34.72 23.04% | 389.29 1,021.35% | 11.88 96.95% | 19.14 61.09% | 61.50 221.26% | 28.52 53.63% | 18.40 35.50% | 16.35 11.12% | 20.94 28.05% | 0.03 99.84% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.25 - | 0.14 43.80% | 0.07 50.63% | 0.00 - | 0.00 79.09% | 0.00 6.47% | 0.14 4,619.11% | 0.00 99.40% | ||||
debt to equity | 0.48 - | 0.21 55.21% | 0.09 56.79% | 0.00 - | 0.00 101.84% | 0.00 24.08% | 0.25 6,119.19% | 0.00 99.49% | ||||
dividend yield | ||||||||||||
earnings yield | -0.24 - | -0.33 36.13% | -32.78 9,829.54% | -0.34 98.96% | -0.03 91.85% | -0.02 29.03% | -0.05 163.88% | -0.11 121.49% | -0.17 49.64% | -0.06 65.03% | -0.00 99.86% | |
enterprise value | 346.82M - | 228.88M 34.01% | -28.22M 112.33% | 37.05M 231.29% | 932.44M 2,416.68% | 1.18B 27.00% | 1.36B 14.56% | 1.66B 22.66% | 1.37B 17.92% | 4.69B 243.59% | 4.32T 92,046.12% | |
enterprise value over ebitda | -3.98 - | -2.75 31.02% | 0.42 115.34% | -1.47 448.45% | -29.08 1,879.94% | -29.11 0.09% | -14.28 50.93% | -8.05 43.63% | -5.63 30.05% | -16.10 185.92% | -11.36K 70,466.02% | |
ev to operating cash flow | -4.48 - | -2.90 35.27% | 0.40 113.62% | -2.10 632.70% | -41.78 1,885.61% | -46.43 11.11% | -32.59 29.80% | -10.56 67.60% | -7.43 29.69% | -20.87 181.03% | -13.34K 63,804.32% | |
ev to sales | ||||||||||||
free cash flow per share | -38.55 - | -28.10 27.12% | -418.11 1,387.99% | -3.38 99.19% | -1.83 45.83% | -1.73 5.86% | -2.71 57.36% | -10.22 276.50% | -11.14 8.94% | -13.13 17.94% | -0.02 99.87% | |
free cash flow yield | -0.21 - | -0.30 44.12% | -34.13 11,166.22% | -0.23 99.33% | -0.02 91.21% | -0.02 23.34% | -0.03 94.68% | -0.09 208.57% | -0.13 42.91% | -0.05 65.57% | -0.00 99.83% | |
graham net net | 22.37 - | 22.09 1.27% | 285.28 1,191.62% | 10.96 96.16% | 18.32 67.16% | 60.93 232.54% | 26.86 55.91% | 15.35 42.85% | 11.68 23.92% | 11.30 3.28% | 0.02 99.81% | |
graham number | 155.64 - | 126.28 18.87% | 1.63K 1,192.27% | 28.25 98.27% | 29.19 3.33% | 40.10 37.39% | 53.66 33.81% | 66.84 24.56% | 62.37 6.69% | 67.28 7.86% | 0.10 99.85% | |
income quality | 0.86 - | 0.92 6.73% | 1.04 13.58% | 0.67 35.86% | 0.72 7.36% | 0.78 8.52% | 0.50 36.22% | 0.78 57.12% | 0.76 2.39% | 0.76 0.11% | 0.87 13.98% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -33.25 - | -37.99 14.23% | -63.72 67.75% | -21.67 65.99% | -57.46 165.15% | -5.30 90.77% | -8.62 62.44% | -74.06 - | 29.93 140.42% | |||
interest debt per share | 12.84 - | 5.73 55.38% | 33.40 483.10% | 0.22 99.33% | 0.05 79.62% | 0.52 1,037.65% | 0.76 46.60% | 0.05 93.30% | 0.05 5.28% | 3.14 6,419.84% | -0.00 100.02% | |
inventory turnover | ||||||||||||
invested capital | 0.48 - | 0.21 55.21% | 0.09 56.79% | 0.00 - | 0.00 101.84% | 0.00 24.08% | 0.25 6,119.19% | 0.00 99.49% | ||||
market cap | 371.91M - | 260.99M 29.82% | 2.09M 99.20% | 77.55M 3,601.81% | 1.12B 1,349.35% | 1.67B 48.39% | 1.40B 15.91% | 1.72B 22.43% | 1.40B 18.40% | 4.97B 254.99% | 4.32T 86,830.32% | |
net current asset value | 46.13M - | 63.81M 38.32% | 49.99M 21.66% | 36.41M 27.17% | 181.96M 399.79% | 476.76M 162.01% | 414.71M 13.02% | 238.14M 42.58% | 194.46M 18.34% | 196.19M 0.89% | 402.07M 104.94% | |
net debt to ebitda | 0.29 - | 0.39 33.79% | 0.45 17.41% | 1.61 254.57% | 5.97 272.06% | 11.89 99.04% | 0.48 95.92% | 0.26 46.86% | 0.15 43.19% | 0.97 560.77% | 0.26 72.98% | |
net income per share | -44.48 - | -30.62 31.16% | -401.56 1,211.45% | -5.07 98.74% | -2.54 49.82% | -2.22 12.84% | -4.73 113.29% | -12.78 170.26% | -14.58 14.06% | -17.47 19.80% | -0.02 99.89% | |
operating cash flow per share | -38.17 - | -28.05 26.53% | -417.77 1,389.50% | -3.38 99.19% | -1.82 46.13% | -1.72 5.42% | -2.70 56.85% | -10.20 277.26% | -11.12 9.04% | -13.12 17.97% | -0.02 99.87% | |
payables turnover | ||||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | ||||||||||||
return on tangible assets | -0.95 - | -0.86 9.66% | -1.01 17.66% | -0.64 36.41% | -0.16 74.70% | -0.07 58.28% | -0.16 143.69% | -0.69 317.68% | -0.88 28.20% | -0.83 6.40% | -0.58 29.34% | |
revenue per share | ||||||||||||
roe | -1.84 - | -1.32 28.00% | -1.36 2.99% | -0.72 46.80% | -0.17 76.41% | -0.07 59.76% | -0.17 154.10% | -0.82 370.72% | -1.23 49.41% | -1.52 23.35% | -0.92 39.21% | |
roic | -1.21 - | -1.06 12.01% | -1.23 15.65% | -0.69 43.54% | -0.17 75.12% | -0.11 38.63% | -0.20 86.39% | -0.84 323.80% | -1.22 46.36% | -1.20 1.83% | -0.94 21.99% | |
sales general and administrative to revenue | ||||||||||||
shareholders equity per share | 24.21 - | 23.15 4.38% | 294.76 1,173.38% | 7.00 97.63% | 14.88 112.77% | 32.24 116.57% | 27.06 16.06% | 15.54 42.59% | 11.86 23.66% | 11.52 2.88% | 0.02 99.81% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | 49.09M - | 65.14M 32.68% | 50.41M 22.61% | 36.41M 27.77% | 182.26M 400.57% | 476.98M 161.71% | 416.56M 12.67% | 239.97M 42.39% | 196.11M 18.28% | 197.39M 0.65% | 405.33M 105.35% | |
tangible book value per share | 24.21 - | 23.15 4.38% | 294.76 1,173.38% | 7.00 97.63% | 14.88 112.77% | 32.24 116.57% | 27.06 16.06% | 15.54 42.59% | 11.86 23.66% | 11.52 2.88% | 0.02 99.81% | |
working capital | 60.03M - | 68.46M 14.03% | 49.99M 26.98% | 36.41M 27.17% | 181.96M 399.79% | 476.76M 162.01% | 415.07M 12.94% | 238.61M 42.51% | 194.85M 18.34% | 245.47M 25.98% | 518.73M 111.32% |
All numbers in (except ratios and percentages)